MDR reversal by deprenylated tetracyclic and hexacyclic analogues of N-acetylardeemin: Confirmation of the ardeemin pharmacophore

Letters in Drug Design and Discovery

Volumn 3, Issue 6, 2006, Pages 369-377

  Avendaño, Carmen ^a   Caballero, Esmeralda ^a   Méndez Vidal, Cristina ^b   De Quesada, Ana R ^b   Menéndez, J Carlos ^a  

^a UNIVERSIDAD COMPLUTENSE DE MADRID   (Spain)

^b Facultad de Medicina   (Spain)

Author keywords

Antitumour drug resistance; Ardeemin; Glycoprotein P 170; MDR; Pharmacophore

Indexed keywords

ALANINE; ANTINEOPLASTIC AGENT; ARDEEMIN DERIVATIVE; AV 200; DOXORUBICIN; FUMITREMORGIN C; GLYCINE DERIVATIVE; HEXACYCLINE; N ACETYLARDEEMIN DERIVATIVE; PACLITAXEL; TETRACYCLINE; UNCLASSIFIED DRUG; VERAPAMIL; VINCRISTINE;

ARTICLE; CANCER CHEMOTHERAPY; CANCER RESISTANCE; CHEMOSENSITIVITY; DRUG SYNTHESIS; EPIMER; MULTIDRUG RESISTANCE; PHARMACOPHORE; PRENYLATION; PRIORITY JOURNAL; STEREOISOMERISM;

EID: 33746668675     PISSN: 15701808     EISSN: None     Source Type: Journal    
DOI: 10.2174/157018006777805558     Document Type: Article

References (19)

1. Avendaño, C.; Menéndez, J. C. Curr. Med. Chem. 2002, 9, 159.
2. Avendaño, C.; Menéndez, J. C. Med. Chem. Rev. Online 2004, 1, 419.
3. Karwowski, J. P.; Jackson, M.; Rasmussen, R. R.; Humphrey, P. E.; Poddig, J. B.; Kohl, W. L.; Scherr, M. H.; Kadam, S.; McAlpine, J. B., J. Antibiot. 1993, 46, 374.
4. Depew, K. M.; Marsden, S. P.; Zatorska, D.; Zatorski, A.; Bornmann, W. G.; Danishefsky, S. J. J. Am. Chem. Soc. 1999, 121, 11953.
5. Chou, T. C.; Depew, K. M.; Zheng, Y. H.; Safer, M. L.; Chan, D.; Helfrich, B.; Zatorska, D.; Zatorski, A.; Bornmann, W.; Danishefsky, S. J. Proc. Natl. Acad. Sci. USA 1998, 95, 8369.
6. Chou, T.-C.; Bertino; J. R.; Danishefsky, S. J.; Kahan, B. D. U. S. Patent 6, 355, 639 (March 12, 2002).
7. For a review, see: Avendaño, C.; Menéndez, J. C. Curr. Org. Chem. 2003, 7, 149.
8. Méndez-Vidal, C.; Quesada, A. R. Cancer Lett. 1998, 132, 45.
9. Rabindran, S. K.; He, H.; Singh, M.; Brown, E.; Collins, K. I.; Annable, T.; Greenberger, L. M. Cancer Res. 1998, 58, 5850.
10. Caballero, E.; Avendaño, C.; Menéndez, J. C. Tetrahedron Asymmetry 1998, 9, 967.
11. Caballero, E.; Avendaño, C.; Menéndez, J. C. Tetrahedron Asymmetry 1998, 9, 3025.
12. Caballero, E.; Avendaño, C.; Menéndez, J. C. Tetrahedron 1999, 55, 14185.
13. Caballero, E.; Avendaño, C.; Menéndez, J. C. J. Org. Chem. 2003, 68, 6944.
14. For a review, see: Eguchi, S. Arkivoc 2005 (ii), 98.
15. For an early example of the use of Meerwein's salt as a Lewis acid, see: Mock, W. L., Hartman, M. E. J. Org. Chem. 1977, 42, 459.
16. Quesada, A. R.; Barbacid, M. M.; Mira, E.; Aracil, M.; Márquez, G. Cancer Lett. 1996, 99, 109.
17. You, M.; Wickramaratne, D. B. M.; Silva, G. L.; Chai, H.; Chagwedera, T. E.; Farnsworth, N. R.; Cordell, G. A.; Kinghorn A. D.; Pezutto, J. M. J. Nat. Prod. 1995, 58, 598.
18. Keller, R. P.; Altermatt, H. J.; Nooter, K.; Poschmann, G.; Laissue, J. A.; Bollinger, P.; Hiestand, P.C. Int. J. Cancer 1992, 50, 593.
19. Mosmann, T. J. Immunol. Methods 1983, 65, 55.